Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.0%

11 terminated/withdrawn out of 220 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

11%

25 trials in Phase 3/4

Results Transparency

3%

5 of 154 completed trials have results

Key Signals

8 recruiting5 with results9 terminated

Enrollment Performance

Analytics

N/A
124(72.1%)
Phase 4
21(12.2%)
Phase 2
14(8.1%)
Phase 1
5(2.9%)
Phase 3
4(2.3%)
Early Phase 1
4(2.3%)
172Total
N/A(124)
Phase 4(21)
Phase 2(14)
Phase 1(5)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (220)

Showing 20 of 220 trials
NCT05084846Completed

InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection

Role: lead

NCT06845033Not ApplicableActive Not Recruiting

Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity

Role: lead

NCT07506369Not ApplicableRecruiting

Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans

Role: lead

NCT07432802Not ApplicableNot Yet Recruiting

Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer

Role: collaborator

NCT07424690Not ApplicableNot Yet Recruiting

Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation

Role: collaborator

NCT06787001Completed

Understanding How Gut and Brain Barriers Are Linked to Inflammation in Obesity

Role: lead

NCT05657054Not ApplicableActive Not Recruiting

Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement

Role: collaborator

NCT07171723Phase 1Recruiting

Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment

Role: lead

NCT06881459Not ApplicableCompleted

The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes

Role: lead

NCT06895408Not ApplicableCompleted

Separate and Combined Extrapancreatic Effects of GIP and GLP-1

Role: lead

NCT06934473Not ApplicableRecruiting

Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

Role: lead

NCT06254365Not ApplicableActive Not Recruiting

Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT

Role: lead

NCT06548009Completed

Serum Metabolics-based Method for Diagnosing Bile Acid Diarrhoea

Role: lead

NCT06435494Not ApplicableEnrolling By Invitation

Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions

Role: lead

NCT05192031Not ApplicableActive Not Recruiting

Implementation of Smoking Cessation Support During Lung Cancer Workup

Role: collaborator

NCT05953064Not ApplicableActive Not Recruiting

Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects

Role: lead

NCT06189001Not ApplicableCompleted

The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with Obesity

Role: lead

NCT06208904Not ApplicableEnrolling By Invitation

The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

Role: lead

NCT06831799Completed

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Role: collaborator

NCT06143267Not ApplicableCompleted

Neuronostatin - a Glucagonotropic Agent in Humans?

Role: lead